Abstract:Glycosylation is one of the most important post-translational modifications (PTM), mediating physiological processes like cell adhesion, cell proliferation, cell signaling, and immune responses. The special functionality of glycosylation for cancer progression and metastasis were reported in recent researches. Analytical methods based on mass spectrometry (MS), especially liquid chromatography mass spectrometry (LC-MS), are the routine practices for protein glycosylation research. However, due to the high complexity and multiformity of glycan structures, as well as the existence of numerous isomers, in-depth analysis of glycosylation ends up as a major challenge for conventional LC-MS-based method. Ion mobility separation is a promising approach to fill the gap as it provides an additional separation dimension for mass spectrometry analysis based on structures and charges of the gas-phase ions. As a technology with an entirely different separation mechanism from that of liquid chromatography, ion mobility spectrometry (IM) has several properties superior to other separation facilities. First of all, unlike liquid chromatography or capillary electrophoresis which demand minutes of separation time, IM only requires a few milliseconds to finish the separation, and it is well compatible with fast mass spectrometry analysis. Besides, as a separation technique for gas phase ions, IM can be modularized and readily integrated into full-fledged LC-MS system. Most importantly, IM is proved to have great potential in glycan isomer discriminations. Given the aforementioned merits, ion mobility mass spectrometry (IM-MS) is gaining attention from glycomics community. This review summarized the basic principles of IM-MS and its applications in protein glycosylation research for the past five years. The means of enhancing isomeric separation performance of glycans were comprehensively discussed, including derivatization, forming metal and other noncovalent adducts, and utilizing high-resolution ion mobility spectrometry implementation. The various approaches of leveraging collision cross section (CCS) values to assist glycan identification and isomer discrimination were also summarized. Furthermore, as two monosaccharides with great biological and pathological significance, the IM-MS applications on fucoses and sialic acids were given special attention. As for glycopeptides, innovative spectra matching algorithms, novel ion activation techniques to facilitate glycan and peptide elucidations, and brand new quantification strategies for isomers were included, along with various glycoproteomic applications of IM-MS on biological samples. Finally, in terms of IM-MS applications in glycoprotein research, investigations of conformational properties, 3D structures, stabilities, and protein-protein interactions were covered. It was concluded that IM-MS is a promising method for protein glycosylation research with great potential.

Liquid-phase separations coupled with ion mobility-mass spectrometry for next-generation biopharmaceutical analysis

Qualitative and quantitative characterization of protein biotherapeutics with liquid chromatography mass spectrometry.

The Potential for Ion Mobility in Pharmaceutical and Clinical Analyses.

High-Throughput Analyses of Therapeutic Antibodies Using High-Field Asymmetric Waveform Ion Mobility Spectrometry Combined with SampleStream and Intact Protein Mass Spectrometry

Universal Automated Immunoaffinity Purification-CE-MS Platform for Accelerating Next Generation Biologic Design.

The role of mass spectrometry in the characterization of biologic protein products

Ion Mobility-Mass Spectrometry and Its Applications in Protein Glycosylation Research

Automated middle-up approach for the characterization of biotherapeutic products by combining on-line hinge-specific digestion with RPLC-HRMS analysis

Current Applications of Liquid Chromatography/Mass Spectrometry in Pharmaceutical Discovery After a Decade of Innovation

Multi‐dimensional technology – Recent advances and applications for biotherapeutic characterization

Advances and Challenges in Analytical Characterization of Biotechnology Products: Mass Spectrometry-Based Approaches to Study Properties and Behavior of Protein Therapeutics.

In-depth size and charge variants characterization of monoclonal antibody with native mass spectrometry

Recent advances in LC-MS based characterization of protein-based bio-therapeutics - mastering analytical challenges posed by the increasing format complexity

Pharmaceutical Applications of Liquid Chromatography Coupled with Mass Spectrometry (LC/MS)

Developing Liquid Chromatography Ion Mobility Mass Spectometry Techniques

Rapid analysis of titer, aggregate, and intact mass of antibody therapeutics using automated multi-dimensional liquid chromatography coupled with native mass spectroscopy

Capillary electrophoresis/mass spectrometry relevant to pharmaceutical and biotechnological applications

Automated ion exchange chromatography screening combined with in silico multifactorial simulation for efficient method development and purification of biopharmaceutical targets

Immunocapture LC–MS methods for pharmacokinetics of large molecule drugs

Recent advancements, challenges, and practical considerations in the mass spectrometry-based analytics of protein biotherapeutics: A viewpoint from the biosimilar industry

Capillary electrophoresis and the biopharmaceutical industry: Therapeutic protein analysis and characterization